NASDAQ:AGEN

Agenus Stock Insider Trading

Healthcare > Biotechnology

Buy AGEN

*Your capital is at risk

$3.07

+0.0300 (+0.99%)

At Close: Jun 23, 2026

Agenus Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 2.91B and sold 0 AGEN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	2.91B shares
● Sell	0 shares
100% Buy Activity Weak Positive Correlation
Buy Signal High Confidence Jun 18, 2025 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 100. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (100% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 12, 2026 Buy	Common Stock A-Award	Armen Garo H See Remarks	Officer	4 925 Value: $16.3K
May 29, 2026 Buy	Common Stock A-Award	Armen Garo H See Remarks	Officer	4 644 Value: $16.3K
May 15, 2026 Buy	Common Stock A-Award	Armen Garo H See Remarks	Officer	4 540 Value: $16.3K
May 01, 2026 Buy	Common Stock A-Award	Armen Garo H See Remarks	Officer	4 233 Value: $16.3K
Apr 24, 2026 Buy	Stock Option A-Award	Armen Garo H See Remarks	Officer	27 750 Value: $108.2K
Apr 24, 2026 Buy	Stock Option A-Award	Armen Garo H See Remarks	Officer	1 000 000 Value: $3.90M
Apr 24, 2026 Buy	Stock Option A-Award	Charette Austin Principal Accounting Officer	Officer	17 619 Value: $68.7K
Apr 24, 2026 Buy	Stock Option A-Award	Harrison Thomas L Director	Director	122 500 Value: $477.8K
Apr 24, 2026 Buy	Stock Option A-Award	O'day Steven J Chief Medical Officer	Officer	95 333 Value: $371.8K
Apr 24, 2026 Buy	Stock Option A-Award	Buell Jennifer See Remarks	Officer	300 000 Value: $1.17M
Apr 24, 2026 Buy	Stock Option A-Award	Hirsch Susan B Director	Director	105 000 Value: $409.5K
Apr 24, 2026 Buy	Stock Option A-Award	Buell Jennifer See Remarks	Officer	5 000 Value: $19.5K
Apr 24, 2026 Buy	Stock Option A-Award	O'day Steven J Chief Medical Officer	Officer	70 000 Value: $273.0K
Apr 24, 2026 Buy	Stock Option A-Award	Wright Timothy Director	Director	105 000 Value: $409.5K
Apr 24, 2026 Buy	Stock Option A-Award	Charette Austin Principal Accounting Officer	Officer	5 000 Value: $19.5K
Apr 24, 2026 Buy	Stock Option A-Award	Armen Garo H See Remarks	Officer	137 550 Value: $536.4K
Apr 24, 2026 Buy	Stock Option A-Award	Corvese Brian Director	Director	210 000 Value: $819.0K
Apr 17, 2026 Buy	Common Stock A-Award	Armen Garo H See Remarks	Officer	3 403 Value: $16.3K
Apr 03, 2026 Buy	Common Stock A-Award	Armen Garo H See Remarks	Officer	4 629 Value: $15.4K
Apr 01, 2026 Buy	Common Stock A-Award	Harrison Thomas L Director	Director	9 228 Value: $30.6K
Apr 01, 2026 Buy	Deferred Stock Units A-Award	Wright Timothy Director	Director	2 448 Value: $8K
Mar 20, 2026 Buy	Common Stock A-Award	Armen Garo H See Remarks	Officer	3 983 Value: $14.8K
Mar 06, 2026 Buy	Common Stock A-Award	Armen Garo H See Remarks	Officer	4 994 Value: $14.8K
Feb 20, 2026 Buy	Common Stock A-Award	Armen Garo H See Remarks	Officer	4 829 Value: $14.8K
Feb 06, 2026 Buy	Common Stock A-Award	Armen Garo H See Remarks	Officer	5 027 Value: $14.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AGENUS INC.

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The...

Read Full Profile Here